Oryzon to present at upcoming international conferences

MADRID, SPAIN and CAMBRIDGE MA.

• BIO International Convention 2018, Boston, Ma, USA

• Jefferies 2018 Global Healthcare Conference, New York, USA

• 14th Spring European Midcap Event, Paris, France

Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that Executive Directors of the company will present at several international reputed conferences in June.

Click here to see the full Press Release